|
November 28, 2022
Once an individual is diagnosed with COVID-19, early treatment with COVID-19-specific agents is the only existing strategy to markedly decrease risk of serious illness. There is ample supply of COVID-19 therapeutic agents, but they have been underused – especially among populations disproportionately impacted by COVID-19, including communities of color, low-income communities, and residents of long-term care facilities. This health alert summarizes relevant resources and guidance and aims to remind providers that all symptomatic patients over the age of 12 years and ≥40 kg with a positive COVID-19 test of any type should be evaluated for treatment with one of the National Institutes for Health recommended treatment options.
| 
